- Home
- FFNW vs INMB Comparison
FFNW vs INMB Comparison
Compare FFNW & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFNW
- INMB
- Stock Information
- Founded
- FFNW 1923
- INMB 2015
- Country
- FFNW United States
- INMB United States
- Employees
- FFNW N/A
- INMB N/A
- Industry
- FFNW Banks
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- FFNW Finance
- INMB Health Care
- Exchange
- FFNW Nasdaq
- INMB Nasdaq
- Market Cap
- FFNW 208.6M
- INMB 176.5M
- IPO Year
- FFNW N/A
- INMB 2019
- Fundamental
- Price
- FFNW $22.74
- INMB $7.69
- Analyst Decision
- FFNW Hold
- INMB Strong Buy
- Analyst Count
- FFNW 2
- INMB 3
- Target Price
- FFNW $22.75
- INMB $24.33
- AVG Volume (30 Days)
- FFNW 64.4K
- INMB 250.3K
- Earning Date
- FFNW 04-29-2025
- INMB 03-27-2025
- Dividend Yield
- FFNW 0.57%
- INMB N/A
- EPS Growth
- FFNW N/A
- INMB N/A
- EPS
- FFNW 0.12
- INMB N/A
- Revenue
- FFNW $37,609,000.00
- INMB $14,000.00
- Revenue This Year
- FFNW N/A
- INMB N/A
- Revenue Next Year
- FFNW $0.82
- INMB N/A
- P/E Ratio
- FFNW $194.40
- INMB N/A
- Revenue Growth
- FFNW N/A
- INMB N/A
- 52 Week Low
- FFNW $18.03
- INMB $4.32
- 52 Week High
- FFNW $23.50
- INMB $12.72
- Technical
- Relative Strength Index (RSI)
- FFNW 66.21
- INMB 46.46
- Support Level
- FFNW $22.60
- INMB $7.07
- Resistance Level
- FFNW $22.76
- INMB $7.94
- Average True Range (ATR)
- FFNW 0.17
- INMB 0.65
- MACD
- FFNW 0.08
- INMB -0.06
- Stochastic Oscillator
- FFNW 97.94
- INMB 34.03
About FFNW First Financial Northwest Inc.
First Financial Northwest Inc is the holding company. The Bank's business consists predominantly of attracting deposits from the general public, combined with borrowing from the FHLB of Des Moines and raising funds in the wholesale market then utilizing these funds to originate one-to-four family residential, multifamily, commercial real estate, construction/land, business, and consumer loans. The Bank's strategic initiatives seek to diversify its loan portfolio and broaden growth opportunities with its current risk tolerance levels and asset/liability objectives.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.